Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 31Recruiting 8Unknown 5Withdrawn 2Terminated 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1Urinary Incontinence 1Testicular Neoplasms 1Prostatic Neoplasms 1Penile Neoplasms 1Neoplasms 1Kidney Neoplasms 1

Interventions

pembrolizumab 438Carboplatin 321Nivolumab 293Cyclophosphamide 285Specimen Handling 257Paclitaxel 249Magnetic Resonance Spectroscopy 249Cisplatin 248Radiotherapy 218Dexamethasone 183Gemcitabine 177Biopsy 177durvalumab 169atezolizumab 149Doxorubicin 140Rituximab 138Lenalidomide 135Docetaxel 131Ipilimumab 130Bevacizumab 128Radiation 121Capecitabine 117Etoposide 116Oxaliplatin 114Fluorouracil 110Pemetrexed 109Radiosurgery 108fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Physical Therapy Modalities × Clear all
NCT05946993 2026-05-01

LIAM Mc

University College Cork

Phase NA Active not recruiting
72 enrolled
Genitourinary

Kidney Neoplasms, Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Urologic Neoplasms

NCT03957434 2025-02-24

Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence

Université de Sherbrooke

Phase NA Active not recruiting
44 enrolled

Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡